Date published: 2026-3-7

1-800-457-3801

SCBT Portrait Logo
Seach Input

SNX12 Inhibitors

SNX12 inhibitors belong to a specific chemical class of compounds that target the Sorting Nexin 12 (SNX12) protein, an essential component of the endosomal sorting machinery within cells. SNX12 is involved in the regulation of endosomal trafficking and plays a crucial role in directing cargo proteins to distinct subcellular compartments. By inhibiting the function of SNX12, these inhibitors modulate intracellular trafficking processes, leading to alterations in various cellular functions. The chemical structures of SNX12 inhibitors vary, but they typically possess specific functional groups that enable them to interact with critical regions of the SNX12 protein, thereby interfering with its normal function. Some of these inhibitors have been designed through rational drug design approaches, employing molecular docking studies and structure-activity relationship (SAR) analyses to optimize their binding affinity and selectivity to the target.

Researchers have conducted in vitro and cellular assays to assess the potency and specificity of SNX12 inhibitors. These studies involve using cell lines and model systems to evaluate the inhibitors' effects on endosomal trafficking and the subsequent impact on various cellular processes, such as receptor internalization, protein sorting, and signal transduction pathways. Furthermore, mechanistic studies are conducted to elucidate the precise molecular interactions between the inhibitors and the SNX12 protein, providing valuable insights into the mode of action of these compounds.Moreover, the use of SNX12 inhibitors in experimental research has shed light on the role of SNX12 in intracellular transport. Through these studies, researchers aim to unravel the complex network of endosomal trafficking and its implications in cellular homeostasis and disease processes. SNX12 inhibitors are valuable tools in deciphering the intricate mechanisms of intracellular trafficking and exploring targets for various disorders where dysregulated endosomal trafficking is implicated.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

S-(4-Nitrobenzyl)-6-thioinosine (NBTI, NBMPR)

38048-32-7sc-200117
50 mg
$163.00
1
(1)

NBTI is a potent and selective inhibitor of ENTIt competitively inhibits nucleoside uptake via ENT4, thereby modulating adenosine signaling.

Dipyridamole

58-32-2sc-200717
sc-200717A
1 g
5 g
$31.00
$102.00
1
(1)

Dipyridamole is a well-known non-selective inhibitor of ENTs, including ENTIt is primarily used as an antiplatelet agent but also exhibits effects on nucleoside transporters, altering adenosine levels and signaling.